Literature DB >> 7540341

Cell-free and cell-associated viremia in pigs after oronasal infection with Aujeszky's disease virus.

H J Nawynck1, M B Pensaert.   

Abstract

Nine pigs were examined for the presence of viremia during the first week after oronasal inoculation of 10(8.0) TCID50 Aujeszky's disease virus (ADV). Blood was taken at 1, 2, 3, 5 and 7 days post inoculation (PI) and the presence of cell-free ADV in plasma and of ADV-infected mononuclear cells was examined by titration and by cocultivation with permissive cells, respectively. The mononuclear cells of 6 of the 9 pigs, collected at 3 and 5 days PI were further separated into subpopulations of enriched monocytes and enriched lymphocytes. Both subpopulations were cocultivated. Nasal secretions were collected from 4 of the 9 pigs for the determination of virus titers and interferon concentrations. Both infected mononuclear cells and cell-free ADV were demonstrated in 5 pigs, infected mononuclear cells only were found in 2 pigs, and neither cell-associated or cell-free ADV were detected in 2 pigs. Two of the 7 viremic animals were positive on one single day, 3 on 2 days, 1 on 3 days and 1 on 4 days. The number of infected cells was approximately 5 times higher in monocytes than in lymphocytes. The highest virus titers were present in those nasal fluids with the lowest alpha-interferon concentration. A correlation between the titer of locally produced ADV in the nose and the presence of a viremia was not found. In conclusion, we can state that a viremia regularly occurs under both cell-free and cell-associated form after an oronasal inoculation of ADV and that monocytes are the most susceptible mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540341     DOI: 10.1016/0378-1135(94)00103-4

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells.

Authors:  H W Favoreel; H J Nauwynck; P Van Oostveldt; T C Mettenleiter; M B Pensaert
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Age-Dependent Differences in Pseudorabies Virus Neuropathogenesis and Associated Cytokine Expression.

Authors:  Sara Verpoest; Brigitte Cay; Herman Favoreel; Nick De Regge
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

3.  Induction and inhibition of apoptosis by pseudorabies virus in the trigeminal ganglion during acute infection of swine.

Authors:  N Alemañ; M I Quiroga; M López-Peña; S Vázquez; F H Guerrero; J M Nieto
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  A tyrosine-based motif in the cytoplasmic tail of pseudorabies virus glycoprotein B is important for both antibody-induced internalization of viral glycoproteins and efficient cell-to-cell spread.

Authors:  Herman W Favoreel; Geert Van Minnebruggen; Hans J Nauwynck; Lynn W Enquist; Maurice B Pensaert
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

5.  Virulent Pseudorabies Virus Infection Induces a Specific and Lethal Systemic Inflammatory Response in Mice.

Authors:  K Laval; J B Vernejoul; J Van Cleemput; O O Koyuncu; L W Enquist
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

6.  Productive replication of nephropathogenic infectious bronchitis virus in peripheral blood monocytic cells, a strategy for viral dissemination and kidney infection in chickens.

Authors:  Vishwanatha R A P Reddy; Ivan Trus; Lowiese M B Desmarets; Yewei Li; Sebastiaan Theuns; Hans J Nauwynck
Journal:  Vet Res       Date:  2016-07-13       Impact factor: 3.683

Review 7.  Pseudorabies Virus: From Pathogenesis to Prevention Strategies.

Authors:  Hui-Hua Zheng; Peng-Fei Fu; Hong-Ying Chen; Zhen-Ya Wang
Journal:  Viruses       Date:  2022-07-27       Impact factor: 5.818

Review 8.  The Neuropathic Itch Caused by Pseudorabies Virus.

Authors:  Kathlyn Laval; Lynn W Enquist
Journal:  Pathogens       Date:  2020-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.